Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a publicly traded Healthcare sector company. As of July 25, 2026, LIMN trades at $0.11 with a market cap of $7.97M and a P/E ratio of -0.27. LIMN moved -8.00% today. Year to date, LIMN is -82.69%; over the trailing twelve months it is -98.69%. Its 52-week range spans $0.10 to $33.66. Rallies surfaces LIMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.11 |
| Market Cap | $7.97M |
| P/E Ratio | -0.27 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.66 |
| 52-Week Low | $0.10 |
| Volume | 2.76M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.21M |
| Gross Margin | 0.00% |
LIMN analyst coverage data. Average price target: $0.00.